Efficacy and pharmacoeconomic advantages of Fufang Huangbai Fluid hydropathic compress in diabetic foot infections: a comparative clinical study with antimicrobial calcium alginate wound dressing

Efficacy and pharmacoeconomic advantages of Fufang Huangbai Fluid hydropathic compress in diabetic foot infections: a comparative clinical study with antimicrobial calcium alginate wound dressing

Objective: To compare the intervention effects and pharmacoeconomic advantages of Fufang Huangbai Fluid (FFHB) hydropathic compress versus Antimicrobial Calcium Alginate Wound Dressing (ACAWD) in the treatment of diabetic foot infections (DFI).Methods: Patients with DF who were hospitalized in the p...

Full description

Bibliographic Details
Main Authors:	Guangyao Yang, Gang Wang, Zhenghong Li, Lijuan Deng, Ning Wang, Xuewan Wang, Tong Zhou, Jingming Zhang, Yin Lei, Tao Wang, Yue Wang, Hanying Shao, Mingya Chen, Keren Zhang, Min Zhou, Xiangbao Wang, Xingfang Liu, Shang Ju
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	Fufang Huangbai Fluid (FFHB) antimicrobial efficacy clinical trial Chinese medicine pharmacoeconomics diabetes
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1285946/full

Similar Items

Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne
by: Di H, et al.
Published: (2023-01-01)

Huangbai Liniment Ameliorates Skin Inflammation in Atopic Dermatitis
by: Ting Zheng, et al.
Published: (2021-08-01)

Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease
by: Lixia Song, et al.
Published: (2022-08-01)

Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis
by: Yanghong Chen, et al.
Published: (2022-03-01)

The components transitive regularity of three dosage forms of Liuwei Dihuang Fufang
by: Zhu Junping, et al.
Published: (2022-03-01)

Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
by: Zhe Chen, et al.
Published: (2022-06-01)

The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice
by: Meiling Yan, et al.
Published: (2023-08-01)

An Optimal Water Resource Allocation Mechanism Based on Ex-Post Verification and Reward in Huangbai River
by: Hui Zhang, et al.
Published: (2021-06-01)

Investigation into the potential mechanism and molecular targets of Fufang Xueshuantong capsule for the treatment of ischemic stroke based on network pharmacology and molecular docking
by: Lei Wang, et al.
Published: (2022-09-01)

Efficacy and safety of Fufang Furong Effervescent Suppository for the treatment of mixed vaginitis: a randomized, multicenter, and non-inferiority study
by: Ying Liu, et al.
Published: (2023-06-01)

Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice
by: Duosheng Luo, et al.
Published: (2019-08-01)

Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney
by: Run Li, et al.
Published: (2023-04-01)

Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sjögren’s syndrome
by: Changming Chen, et al.
Published: (2023-06-01)

Anticancer Effects of Fufang Yiliu Yin Formula on Colorectal Cancer Through Modulation of the PI3K/Akt Pathway and BCL-2 Family Proteins
by: Bingzi Dong, et al.
Published: (2020-08-01)

In vitro and in vivo antiviral effect of Fufang Yinhua Jiedu granules (FFYH) combined with oseltamivir against influenza A virus
by: Zhihui Zheng, et al.
Published: (2023-02-01)

Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis
by: Jianchun Huang, et al.
Published: (2016-10-01)

Pharmacoeconomics of Bronchial Asthma
by: Ivanova Zlatina I., et al.
Published: (2019-06-01)

Evaluation of Sodium Hypochlorite Irrigant, Bingpeng Irrigant, and Fufang Bingpeng Irrigant as Endodontic Irrigants During Passive Ultrasonic Irrigation
by: Yan Shi, et al.
Published: (2019-05-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Protective effects of Fufang Ejiao Jiang against aplastic anemia assessed by network pharmacology and metabolomics strategy
by: He Dan, et al.
Published: (2021-12-01)

Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
by: V. V. Ivanov, et al.
Published: (2015-04-01)

Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
by: LI Shunping, et al.
Published: (2022-10-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood
by: Shizhe Li, et al.
Published: (2018-01-01)

Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
by: Minji Wi, et al.
Published: (2023-09-01)

Pharmacoeconomics in Africa: needs, prospect and challenges
by: Temitope Ben-Ajepe, et al.
Published: (2021-12-01)

Outlook of Pharmacoeconomics and its status in Nepal
by: Sabita Paudel
Published: (2018-03-01)

Pharmacoeconomic particulars of ovaries cancer’s treatment
by: V N Zhurman, et al.
Published: (2015-06-01)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
by: Milewska S, et al.
Published: (2021-09-01)

Development of a pharmacoeconomic registry: an example using hormonal contraceptives
by: Annesha White, et al.
Published: (2021-03-01)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018-01-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Pharmacoeconomic aspects of COVID-19 treatment
by: I. V. Rogova, et al.
Published: (2021-10-01)

PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
by: R. I. Yagudina, et al.
Published: (2015-03-01)

PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
by: D. D. Morikov, et al.
Published: (2017-04-01)

Methodology of pharmacoeconomic evaluation studies in Iran: a brief report
by: Sara Emamgholipour, et al.
Published: (2023-01-01)

PHARMACOECONOMIC ANALYSIS OF EFFICACY OF DIFFERENT MODES OF ANTIBIOTIC PROPHYLAXIS IN CHOLECYSTECTOMY
by: A. N. Poborskiy, et al.
Published: (2016-10-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Editorial: Challenges of Pharmacoeconomics in Global Health Arena
by: Mihajlo Jakovljevic, et al.
Published: (2018-12-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy
by: Reshetko O.V., et al.
Published: (2015-09-01)